Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Age-Associated Memory Impairment:A Role for Catecholamines
Neurol 40:526-530, McEntee,W.J.&Crook,T.H., 1990
Alcoholic Dementia:A Hypothesis
Lancet 1:1184-1186, Lishman,W.A., 1986
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985
Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982
Neurotransmitters & CNS Disease, Dementia
Lancet 2:1200-1204, Rossor,M.N., 1982
Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982
Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981
Biochemical Evidence Of Dysfunction Of Brain Neurotransmitters In The Lesch-Nyhan Syndrome
NEJM 305:1106-1111, Lloyd,K.G.,et al, 1981
Glycine Encephalopathy
NEJM 298:687, Ch'ien,L.T., 1978